Anti-Cholesterol Drug Pulled Off Market
FOR IMMEDIATE RELEASE
Click here to download this
press release (.PDF)
Anti-Cholesterol Drug Pulled Off Market
OREM, UTAH—A recent announcement that Bayer A.G., a pharmaceutical and chemical
conglomerate, is voluntarily pulling Baycol, its highly profitable
cholesterol-lowering drug, off the
market is good news for consumers who prefer to maintain their cholesterol
through diet or natural
supplements.
The voluntary move, which is supported by the United States Food and Drug
Administration, comes
after the agency received reports of 31 deaths that may be associated with the
use of Baycol, 12 of
which involved concomitant gemfibrozil use. The medication reportedly caused
rhabdomyolysis, an
unusual condition in which muscle tissue breaks down.
Unicity product Bios Life 2® is a clinically tested, natural, and effective
nutrient drink mix that helps
support normal cholesterol and blood sugar levels. This flagship Rexall brand
product was recently
featured on a major news television program for its cholesterol-lowering
benefits. Bios Life 2® is used
by thousands.
For more information about the Baycol recall, visit www.fda.gov. To find out
more about Bios Life 2®,
visit
www.unicitynetwork.com
Baycol contains statins, which make cholesterol levels plummet and have
revolutionized the treatment
of high blood pressure since they were introduced in the 1980s. From the
beginning, experts noted
that statins caused muscle problems; however, the extent of those problems is
only now being discovered.
Officially launched on July 1, 2001, Unicity Network™ represents the
coming together of Rexall Showcase International and Enrich International, two
of the most respected
and most successful network marketing and nutritional companies in the industry.
The launch of
the company has captured worldwide attention and has been featured in several
industry publications.
The company operates in ten different countries.
Visit
website at www.BL2.info
Click here to download this
press release (.PDF)
|